Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 4 | 0 | 993,40 € | 1.034,6 € | 4,15 % |
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | 741,50 € | 824,47 € | 11,19 % |
| Vertex Pharmaceuticals Inc. | 55 | 2 | 4 | 0 | 456,30 € | 450,36 € | -1,30 % |
| Amgen Inc. | 25 | 0 | 1 | 0 | 308,45 € | 304,65 € | -1,23 % |
| Biogen Inc. | 51 | 1 | 4 | 0 | 194,45 € | 291,49 € | 49,91 % |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | 165,66 € | 200,06 € | 20,76 % |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | 185,00 € | 195,00 € | 5,41 % |
| Johnson & Johnson | 40 | 1 | 5 | 0 | 147,96 € | 187,15 € | 26,49 % |
| AbbVie Inc. | 32 | 0 | 8 | 0 | 170,56 € | 176,97 € | 3,76 % |
| AstraZeneca plc | 2 | 0 | 0 | 0 | 143,80 € | 165,00 € | 14,74 % |
| Merck KGaA | 3 | 2 | 0 | 1 | 161,50 € | 146,00 € | -9,60 % |
| Novo Nordisk A/S ADR | 20 | 1 | 1 | 0 | 117,00 € | 144,02 € | 23,09 % |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | 136,05 € | 130,00 € | -4,45 % |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | 115,40 € | 124,97 € | 8,30 % |
| Abbott Laboratories | 19 | 0 | 1 | 0 | 96,93 € | 116,25 € | 19,93 % |
| Novartis AG ADR | 3 | 0 | 1 | 0 | 102,00 € | 112,40 € | 10,19 % |
| Ipsen S.A. | 1 | 0 | 0 | 0 | 103,90 € | 109,00 € | 4,91 % |
| BioMarin Pharmaceutical Inc. | 19 | 0 | 1 | 0 | 77,90 € | 102,61 € | 31,72 % |
| Sanofi S.A. | 3 | 0 | 0 | 0 | 96,21 € | 99,50 € | 3,42 % |
| Gilead Sciences Inc | 11 | 1 | 1 | 0 | 70,94 € | 85,27 € | 20,21 % |
| Incyte Corp. | 13 | 2 | 1 | 1 | 63,20 € | 77,67 € | 22,90 % |
| Exact Sciences | 15 | 0 | 1 | 0 | 41,73 € | 77,33 € | 85,31 % |
| Sanofi S.A. ADR | 11 | 0 | 2 | 0 | 48,40 € | 55,25 € | 14,16 % |
| GSK plc ADR | 6 | 0 | 1 | 0 | 36,80 € | 49,33 € | 34,04 % |
| Bayer AG | 16 | 3 | 3 | 2 | 27,38 € | 45,00 € | 64,35 % |